Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 234.14 Thousand USD | -5.92% |
| 2022 | 248.87 Thousand USD | 19.93% |
| 2021 | 207.52 Thousand USD | 14.59% |
| 2020 | 181.09 Thousand USD | -13.98% |
| 2019 | 210.52 Thousand USD | 3.65% |
| 2018 | 203.12 Thousand USD | -5.03% |
| 2017 | 213.88 Thousand USD | 4.81% |
| 2016 | 204.07 Thousand USD | -30.24% |
| 2015 | 292.53 Thousand USD | -12.94% |
| 2014 | 336.02 Thousand USD | 62.39% |
| 2013 | 206.92 Thousand USD | -28.77% |
| 2012 | 290.5 Thousand USD | 57.82% |
| 2011 | 184.07 Thousand USD | 251.55% |
| 2010 | 52.36 Thousand USD | 24.76% |
| 2009 | 41.96 Thousand USD | -41.33% |
| 2008 | 71.52 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 221.72 Thousand USD | -5.3% |
| 2024 Q2 | 218.31 Thousand USD | -1.54% |
| 2023 Q2 | 219.49 Thousand USD | -5.13% |
| 2023 FY | 234.14 Thousand USD | -5.92% |
| 2023 Q4 | 234.14 Thousand USD | 14.36% |
| 2023 Q3 | 204.73 Thousand USD | -6.72% |
| 2023 Q1 | 231.36 Thousand USD | -7.03% |
| 2022 Q1 | 204.46 Thousand USD | -1.47% |
| 2022 FY | 248.87 Thousand USD | 19.93% |
| 2022 Q3 | 267.54 Thousand USD | 32.63% |
| 2022 Q4 | 248.87 Thousand USD | -6.98% |
| 2022 Q2 | 201.71 Thousand USD | -1.34% |
| 2021 Q3 | 221.66 Thousand USD | 15.72% |
| 2021 Q2 | 191.55 Thousand USD | -4.05% |
| 2021 FY | 207.52 Thousand USD | 14.59% |
| 2021 Q1 | 199.63 Thousand USD | 10.24% |
| 2021 Q4 | 207.52 Thousand USD | -6.38% |
| 2020 Q1 | 201.07 Thousand USD | -4.49% |
| 2020 Q3 | 179.71 Thousand USD | -7.18% |
| 2020 FY | 181.09 Thousand USD | -13.98% |
| 2020 Q4 | 181.09 Thousand USD | 0.77% |
| 2020 Q2 | 193.62 Thousand USD | -3.71% |
| 2019 Q3 | 226.61 Thousand USD | -10.35% |
| 2019 FY | 210.52 Thousand USD | 3.65% |
| 2019 Q1 | 254.38 Thousand USD | 25.24% |
| 2019 Q2 | 252.77 Thousand USD | -0.63% |
| 2019 Q4 | 210.52 Thousand USD | -7.1% |
| 2018 FY | 203.12 Thousand USD | -5.03% |
| 2018 Q2 | 182.34 Thousand USD | -9.28% |
| 2018 Q4 | 203.12 Thousand USD | -6.96% |
| 2018 Q3 | 218.3 Thousand USD | 19.72% |
| 2018 Q1 | 201 Thousand USD | -6.02% |
| 2017 Q4 | 213.88 Thousand USD | 0.79% |
| 2017 FY | 213.88 Thousand USD | 4.81% |
| 2017 Q1 | 186.54 Thousand USD | -8.59% |
| 2017 Q2 | 175.02 Thousand USD | -6.18% |
| 2017 Q3 | 212.2 Thousand USD | 21.25% |
| 2016 FY | 204.07 Thousand USD | -30.24% |
| 2016 Q1 | 277.4 Thousand USD | -5.17% |
| 2016 Q4 | 204.07 Thousand USD | -8.53% |
| 2016 Q3 | 223.11 Thousand USD | -6.92% |
| 2016 Q2 | 239.69 Thousand USD | -13.59% |
| 2015 Q2 | 285.28 Thousand USD | -8.19% |
| 2015 FY | 292.53 Thousand USD | -12.94% |
| 2015 Q4 | 292.53 Thousand USD | 7.93% |
| 2015 Q3 | 271.04 Thousand USD | -4.99% |
| 2015 Q1 | 310.73 Thousand USD | -7.53% |
| 2014 Q2 | 239.67 Thousand USD | 4.95% |
| 2014 Q1 | 228.37 Thousand USD | 10.36% |
| 2014 FY | 336.02 Thousand USD | 62.39% |
| 2014 Q4 | 336.02 Thousand USD | 28.47% |
| 2014 Q3 | 261.54 Thousand USD | 9.13% |
| 2013 Q3 | 254.1 Thousand USD | -1.94% |
| 2013 Q2 | 259.13 Thousand USD | -3.3% |
| 2013 Q1 | 267.97 Thousand USD | -7.76% |
| 2013 FY | 206.92 Thousand USD | -28.77% |
| 2013 Q4 | 206.92 Thousand USD | -18.57% |
| 2012 Q3 | 322.03 Thousand USD | -2.24% |
| 2012 Q4 | 290.5 Thousand USD | -9.79% |
| 2012 Q1 | 311.97 Thousand USD | 69.49% |
| 2012 Q2 | 329.4 Thousand USD | 5.59% |
| 2012 FY | 290.5 Thousand USD | 57.82% |
| 2011 Q1 | 54.62 Thousand USD | 4.32% |
| 2011 Q2 | 67.23 Thousand USD | 23.09% |
| 2011 FY | 184.07 Thousand USD | 251.55% |
| 2011 Q3 | 118.15 Thousand USD | 75.74% |
| 2011 Q4 | 184.07 Thousand USD | 55.78% |
| 2010 FY | 52.36 Thousand USD | 24.76% |
| 2010 Q3 | 41.26 Thousand USD | -24.78% |
| 2010 Q2 | 54.86 Thousand USD | -7.45% |
| 2010 Q1 | 59.27 Thousand USD | 41.25% |
| 2010 Q4 | 52.36 Thousand USD | 26.89% |
| 2009 FY | 41.96 Thousand USD | -41.33% |
| 2009 Q4 | 41.96 Thousand USD | -5.48% |
| 2009 Q3 | 44.4 Thousand USD | -9.56% |
| 2009 Q2 | 49.09 Thousand USD | -12.49% |
| 2009 Q1 | 56.1 Thousand USD | -21.57% |
| 2008 FY | 71.52 Thousand USD | 0.0% |
| 2008 Q4 | 71.52 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Avitar, Inc. | 225.15 Thousand USD | -3.992% |
| BioElectronics Corporation | 41.05 Thousand USD | -470.362% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -81.00 USD | 289167.901% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -698.993% |
| Polarean Imaging plc | 2.21 Million USD | 89.447% |
| AVITA Medical, Inc. | 3.12 Million USD | 92.499% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.828% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -146.728% |
| QHSLab, Inc. | 25.18 Thousand USD | -829.848% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.828% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 97.902% |
| Escalon Medical Corp. | 1.61 Million USD | 85.485% |
| Aurora Spine Corporation | 3.54 Million USD | 93.393% |
| BrainsWay Ltd. | 3.71 Million USD | 93.701% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 98.37% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.944% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -406.511% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -136.159% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -1820.796% |
| Nanomix Corporation | - USD | -Infinity% |
| Theraclion SA | 3.05 Million EUR | 92.335% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -86.304% |
| Positron Corporation | 1.25 Million USD | 81.371% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -241.733% |
| Lombard Medical, Inc. | 6.87 Million USD | 96.595% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.851% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -42.897% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -81.509% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 92.066% |
| VMS Rehab Systems, Inc. | 1.33 USD | -17604787.218% |
| Guided Therapeutics, Inc. | 632 Thousand USD | 62.952% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -173.553% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | 25.291% |
| Urologix, Inc. | 1.39 Million USD | 83.239% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -33.761% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 89.389% |
| SS Innovations International, Inc. | 6.32 Million USD | 96.299% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.99% |
| NIOX Group Plc | 6.11 Million USD | 96.168% |
| Fuse Medical, Inc. | 9.11 Million USD | 97.433% |
| Broncus Holding Corporation | 4.7 Million USD | 95.026% |
| Brain Scientific Inc. | 149.55 Thousand USD | -56.558% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | 23.208% |
| Health Logic Interactive Inc. | -4511.80 USD | 5289.614% |